ParissaTabrizianMD
General Surgery • New York, NYTransplantation
Associate, Surgery, Icahn School of Medicine at Mount Sinai
Are you Dr. Tabrizian?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 41 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
5 E 98th St
New York, NY 10029Phone+1 212-659-8084Fax+1 646-537-9238
Summary
- Dr. Parissa Tabrizian, MD is a general surgeon in New York, New York. She is currently licensed to practice medicine in New York. She is affiliated with The Mount Sinai Hospital and is an Associate at Icahn School of Medicine at Mount Sinai.
Education & Training
Icahn School of Medicine at Mount SinaiResidency, Surgery, 2005 - 2006
University of Vienna Faculty of MedicineClass of 2002
Certifications & Licensure
NY State Medical License 2011 - 2026
American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- General Anesthetics in CAncer REsection Surgery (GA-CARES) Trial Start of enrollment: 2017 Jan 31
Publications & Presentations
PubMed
- 5 citationsIntention-to-treat outcomes of patients with hepatocellular carcinoma receiving immunotherapy before liver transplant: The multicenter VITALITY study.Parissa Tabrizian, Matthew L Holzner, Veeral Ajmera, Amy K Kim, Kali Zhou
Journal of Hepatology. 2025-03-01 - Predicting futile outcomes following deceased donor liver transplantation in non-Hcc patients with MELD-Na score above 30: a retrospective international multicenter co...Hye-Sung Jo, Young-In Yoon, Ki-Hun Kim, Parissa Tabrizian, Rebecca Marino
International Journal of Surgery. 2025-02-05 - Neoadjuvant atezolizumab plus bevacizumab prior liver transplantation for hepatocellular carcinoma.Parissa Tabrizian, Rebecca Marino, Sherrie Bhoori, Marcus Zeitlhoefler, Neil Mehta
JHEP Reports. 2025-02-01
Press Mentions
Immunotherapy Shows Promise in Downstaging Liver Tumors Prior to TransplantNovember 19th, 2024- "Downstaging" Liver Cancer Before Transplant Improves OutcomesJuly 25th, 2022
- Shrinking Liver Cancer Tumors Before Transplant Yields Excellent Outcomes, Mount Sinai Researchers ReportJuly 20th, 2022
Professional Memberships
- Member
